CEO Message


Thank you for visiting Amphastar Pharmaceuticals, Inc., a biopharmaceutical manufacturer focused on bringing safe, affordable drugs to the patient. We have been able to make great strides in accomplishing this goal through the strategic acquisition of facilities such as International Medication Systems, Ltd., Armstrong Pharmaceuticals, Inc., Amphastar Nanjing Pharmaceuticals, Ltd. and Amphastar France Pharmaceuticals. We have successfully capitalized on each facility’s distinct talents and capabilities to grow their individual products and go a step further by blending their attributes and working hand-in-hand to create new products and capabilities.


Since Amphastar’s inception in 1996, we have shown tremendous growth and  currently employ more than 1,500 people, producing over 20 products both in the U.S. and abroad. Additionally, we have over 20 products in various stages of development.

Going forward we will continue to diversify our products and expand our distribution of those products. We will continue to provide affordable High Quality products through High Efficiency, and High Technology for those that depend on them. At inception, we set our sights on Amphastar becoming a recognized “American Pharmaceutical Star” - Amphastar.



Copyright © 2022 Amphastar Pharmaceuticals, Inc.

Privacy      Terms & Conditions

This site is intended for residents of the United States